 |
110 Diseases |  |
151 Trials |
|
151 Trials |  |
7120 News |  |
| «12...75767778798081828384858687 |
- |||||||||| Prolia (denosumab) / Amgen, Daiichi Sankyo
New P3 trial: Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids (clinicaltrials.gov) - Apr 10, 2012
P3, N=776, Recruiting, Sponsor: Amgen
- |||||||||| Evenity (romosozumab-aqqg) / Astellas, Amgen, UCB
New P3 trial: FRAME: Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis (clinicaltrials.gov) - Apr 10, 2012
P3, N=7180, Active, not recruiting, Sponsor: Amgen
- Prolia (denosumab) / Amgen
New P4 trial: Denosumab in Primary Hyperparathyroidism (clinicaltrials.gov) - Mar 18, 2012
P4, N=28, Recruiting, Sponsor: John P. Bilezikian
- Prolia (denosumab) / Amgen
New P2 trial, Tumor cell: Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer (clinicaltrials.gov) - Mar 5, 2012
P2, N=45, Recruiting, Sponsor: Hope Rugo, MD
- |||||||||| Prolia (denosumab) / Amgen, Daiichi Sankyo
New P3 trial: A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab (clinicaltrials.gov) - Dec 14, 2011
P3, N=250, Completed, Sponsor: GlaxoSmithKline
- Prolia (denosumab) / Amgen, Daiichi Sankyo
New P4 trial: Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis (clinicaltrials.gov) - Nov 3, 2011
P4, N=40, Active, not recruiting, Sponsor: Tuen Mun Hospital
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
New P1 trial: Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis (clinicaltrials.gov) - Nov 2, 2011
P1, N=32, Completed, Sponsor: Amgen
- |||||||||| Prolia (denosumab) / Amgen, Daiichi Sankyo
New P3 trial: A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab (clinicaltrials.gov) - Oct 20, 2011
P3, N=135, Completed, Sponsor: GlaxoSmithKline
- ||| Prolia (denosumab) / Amgen, Daiichi Sankyo
Enrollment closed: Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis (clinicaltrials.gov) - Oct 19, 2011
P2, N=90, Active, not recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting
- Prolia (denosumab) / Amgen
New P2 trial, Surgery: A Randomized, Placebo-controlled, Double-blind, Two-center Study with Denosumab in Subjects Undergoing Elective Total Knee Replacement Surgery En randomiserad, placebokontrollerad, dubbelblind, tv (EUDRACT) - Oct 4, 2011
P2, N=50, Ongoing, Sponsor: H
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial completion: The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam (clinicaltrials.gov) - Aug 31, 2011
P1, N=30, Completed, Sponsor: Amgen
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||||||||| Prolia (denosumab) / Amgen, Daiichi Sankyo
New P3 trial, Metastases: Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer (clinicaltrials.gov) - Aug 16, 2011
P3, N=400, Enrolling by invitation, Sponsor: Amgen